Jill Leversage, Director at Aurinia Pharmaceuticals Inc. (AUPH), sold 9,630 shares at $11.26 ($108K) on 2023-05-23, disclosed to the SEC on 2023-05-23.
Open-market sale of $108k AUPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.26 | 4,815 | $54K | 50.0% |
| 2 | $11.26 | 4,815 | $54K | 50.0% |
| Total | $11.26 avg | 9,630 | $108K | 100% |
| Filing → |
| AUPH | BUY | 2021-05-12 | $27K | — | Filing → |
| AUPH | BUY | 2021-02-02 | $26K | — | Filing → |